These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 35418220)

  • 21. Metformin increases APP expression and processing via oxidative stress, mitochondrial dysfunction and NF-κB activation: Use of insulin to attenuate metformin's effect.
    Picone P; Nuzzo D; Caruana L; Messina E; Barera A; Vasto S; Di Carlo M
    Biochim Biophys Acta; 2015 May; 1853(5):1046-59. PubMed ID: 25667085
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metformin use history and genome-wide DNA methylation profile: potential molecular mechanism for aging and longevity.
    Marra PS; Yamanashi T; Crutchley KJ; Wahba NE; Anderson ZM; Modukuri M; Chang G; Tran T; Iwata M; Cho HR; Shinozaki G
    Aging (Albany NY); 2023 Feb; 15(3):601-616. PubMed ID: 36734879
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New mechanism of metformin action mediated by lysosomal presenilin enhancer 2.
    Sugawara K; Ogawa W
    J Diabetes Investig; 2023 Jan; 14(1):12-14. PubMed ID: 36308027
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metformin and retinal diseases in preclinical and clinical studies: Insights and review of literature.
    Amin SV; Khanna S; Parvar SP; Shaw LT; Dao D; Hariprasad SM; Skondra D
    Exp Biol Med (Maywood); 2022 Feb; 247(4):317-329. PubMed ID: 35068220
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metformin's Modulatory Effects on miRNAs Function in Cancer Stem Cells-A Systematic Review.
    Malinowski B; Musiała N; Wiciński M
    Cells; 2020 Jun; 9(6):. PubMed ID: 32512882
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metformin induces a senescence-associated gene signature in breast cancer cells.
    Williams CC; Singleton BA; Llopis SD; Skripnikova EV
    J Health Care Poor Underserved; 2013 Feb; 24(1 Suppl):93-103. PubMed ID: 23395946
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metformin Prevents Hyperglycemia-Associated, Oxidative Stress-Induced Vascular Endothelial Dysfunction: Essential Role for the Orphan Nuclear Receptor Human Nuclear Receptor 4A1 (Nur77).
    Venu VKP; Saifeddine M; Mihara K; Faiza M; Gorobets E; Flewelling AJ; Derksen DJ; Hirota SA; Marei I; Al-Majid D; Motahhary M; Ding H; Triggle CR; Hollenberg MD
    Mol Pharmacol; 2021 Nov; 100(5):428-455. PubMed ID: 34452975
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Current understanding of metformin effect on the control of hyperglycemia in diabetes.
    An H; He L
    J Endocrinol; 2016 Mar; 228(3):R97-106. PubMed ID: 26743209
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Metformin is a possible glucagon-like peptide 1 stimulator].
    Bahne E; Brønden A; Vilsbøll T; Knop FK
    Ugeskr Laeger; 2018 Mar; 180(12):. PubMed ID: 29559078
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metformin in nucleus accumbens core reduces cue-induced cocaine seeking in male and female rats.
    Chan A; Willard A; Mulloy S; Ibrahim N; Sciaccotta A; Schonfeld M; Spencer SM
    Addict Biol; 2022 May; 27(3):e13165. PubMed ID: 35470560
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metformin and cancer: doses, mechanisms and the dandelion and hormetic phenomena.
    Martin-Castillo B; Vazquez-Martin A; Oliveras-Ferraros C; Menendez JA
    Cell Cycle; 2010 Mar; 9(6):1057-64. PubMed ID: 20305377
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metformin: Adjunct Therapy in Cancer Treatment.
    Lurati AR
    Workplace Health Saf; 2017 Dec; 65(12):568-571. PubMed ID: 28703040
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Current understanding of the pharmacogenomics of metformin.
    Zolk O
    Clin Pharmacol Ther; 2009 Dec; 86(6):595-8. PubMed ID: 19915604
    [TBL] [Abstract][Full Text] [Related]  

  • 34. DEPTOR-related mTOR suppression is involved in metformin's anti-cancer action in human liver cancer cells.
    Obara A; Fujita Y; Abudukadier A; Fukushima T; Oguri Y; Ogura M; Harashima S; Hosokawa M; Inagaki N
    Biochem Biophys Res Commun; 2015 May; 460(4):1047-52. PubMed ID: 25843797
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of AMPK-dependent pathways in cellular and molecular mechanisms of metformin: a new perspective for treatment and prevention of diseases.
    Hasanvand A
    Inflammopharmacology; 2022 Jun; 30(3):775-788. PubMed ID: 35419709
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Involvement of glucagon-like peptide-1 in the glucose-lowering effect of metformin.
    Bahne E; Hansen M; Brønden A; Sonne DP; Vilsbøll T; Knop FK
    Diabetes Obes Metab; 2016 Oct; 18(10):955-61. PubMed ID: 27265206
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metformin, lipids and atherosclerosis prevention.
    Jenkins AJ; Welsh P; Petrie JR
    Curr Opin Lipidol; 2018 Aug; 29(4):346-353. PubMed ID: 29878903
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metformin's Mechanism of Action Is Stimulation of the Biosynthesis of the Natural Cyclic AMP Antagonist Prostaglandylinositol Cyclic Phosphate (Cyclic PIP).
    Wasner HK
    Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216316
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Crucial microRNAs and genes in metformin's anti-pancreatic cancer effect explored by microRNA-mRNA integrated analysis.
    Li Y; Li L; Zhang G; Wang Y; Chen H; Kong R; Pan S; Sun B
    Invest New Drugs; 2018 Feb; 36(1):20-27. PubMed ID: 28875433
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prenatal metformin exposure or organic cation transporter 3 knock-out curbs social interaction preference in male mice.
    Garbarino VR; Santos TA; Nelson AR; Zhang WQ; Smolik CM; Javors MA; Daws LC; Gould GG
    Pharmacol Res; 2019 Feb; 140():21-32. PubMed ID: 30423430
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.